Authors
Latest:
Jeff P. Sharman, MD, on Results from the ELEVATE TN Study in CLLThe Willamette Valley Cancer Institute and Research Center expert talks about the results of the ELEVATE TN trial at the ASH Annual Meeting and Exposition.
Latest:
Diego Villa, MD, FRCPC, Discusses Bendamustine and Rituximab as Induction Therapy in MCLDiego Villa, MD, FRCPC, elaborated on the progress made with bendamustine and rituximab as induction therapy for transplant eligible and ineligible patients with mantle cell lymphoma.
Latest:
Courtney DiNardo, MD, MSCE, on Enasidenib Plus Azacitidine in Newly Diagnosed AMLCourtney DiNardo, MD, MSCE, elaborated on interim phase II results regarding enasibenib plus azacitidine in patients with newly diagnosed acute myeloid leukemia, and the results from the QUAZAR trial.
Latest:
Location, Location, Location: Approaches to Retroperitoneal Vascular LeiomyosarcomaSarcomas are relatively rare malignant tumors that arise from mesenchymal cells and therefore encompass a variety of histologies and can occur in any anatomic compartment. The incidence of sarcoma is estimated at 1% of all new cancer diagnoses in the United States annually. Approximately 15% of soft tissue sarcomas occur in the retroperitoneum, with about 1600 new retroperitoneal sarcoma cases diagnosed in the United States each year.
Latest:
Location, Location, Location: Approaches to Retroperitoneal Vascular LeiomyosarcomaSarcomas are relatively rare malignant tumors that arise from mesenchymal cells and therefore encompass a variety of histologies and can occur in any anatomic compartment. The incidence of sarcoma is estimated at 1% of all new cancer diagnoses in the United States annually. Approximately 15% of soft tissue sarcomas occur in the retroperitoneum, with about 1600 new retroperitoneal sarcoma cases diagnosed in the United States each year.
Latest:
Finding the Next Line of Treatment in MelanomaFor those with early-stage melanoma, surgery may be the only treatment needed. However, when melanoma has spread beyond the skin, additional treatments before or after surgery may be necessary.
Latest:
A 65-Year-Old Man With Back Pain and Imaging Findings of Spinal Cord CompressionMehmet S. Copur, MD, and colleagues examine the case of a 65-year-old who presented with back pain and a large T8 spinal mass, leading to a diagnosis of multiple myeloma with spinal cord compromise.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non–Small Cell Lung CancerA 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood.
Latest:
Encorafenib Combo Shows Universal Activity in CRC Prognostic GroupsAdditional progression-free survival data from the phase 3 BREAKWATER trial will be presented at future meetings.
Latest:
Joseph Kim, MD, on Liquid Biopsies as a Diagnostic for GI CancersThe chief of surgical oncology at the UK Markey Cancer Center discussed liquid biopsies and their potential importance for diagnosing gastric cancer.
Latest:
Synchronous Bilateral Lung Cancer With Discordant HistologyMedical oncologsts discuss the case of a 70-year old woman with synchronous multiple primary lung cancer.
Latest:
Synchronous Bilateral Lung Cancer With Discordant HistologyMedical oncologsts discuss the case of a 70-year old woman with synchronous multiple primary lung cancer.
Latest:
Synchronous Bilateral Lung Cancer With Discordant HistologyMedical oncologsts discuss the case of a 70-year old woman with synchronous multiple primary lung cancer.
Latest:
Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia.
Latest:
Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia.
Latest:
Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia.
Latest:
Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia.
Latest:
CARTITUDE-4 Study: Cilta-Cel vs Standard of Care for Lenalidomide-Refractory Multiple MyelomaPanelists review the CARTITUDE-4 study results highlighting the efficacy of cilta-cel in lenalidomide-refractory multiple myeloma, addressing implementation challenges and patient preferences in varying relapse scenarios.
Latest:
Challenges in Optimizing Sequencing Strategies in R/R MMExperts on multiple myeloma outline current challenges in determining the optimal treatment strategy for patients with relapsed/refractory disease who are eligible for bispecifics and CAR T-cell therapy.
Latest:
Rogerio Lilenbaum, MD, Discusses Immunotherapy and Targeted Therapy for Lung CancerRogerio Lilenbaum, MD, talked about the state of lung cancer in regards to immunotherapy and targeted therapy at the 17th Annual Winter Lung Conference in Miami Beach, Florida.
Latest:
Walter Curran, MD, on Integration of Immunotherapy with Radiation TherapyWalter Curran, MD, detailed his presentation on immunotherapy and radiation therapy, and how integrating the 2 treatment options presents an exciting opportunity moving forward.
Latest:
Andrea Price, APN, Discusses Electronic Medical Records in CAR T-Cell TherapyThe associate director for clinical research at the Washington University School of Medicine spoke about the value and challenges of using EMRs in CAR T-cell therapy.
Latest:
Dylan Essner on Documentation Tools for CAR T-Cell TherapyDylan Essner discussed the implementation of documentation tools and CRS, ICANS and ICE flow sheets within CAR T-cell therapy.
Latest:
Mark Schroeder, MD, Discusses Treatment Options for Acute GvHDMark Schroeder, MD, detailed 3 different potential treatments for acute graft versus host disease.
Latest:
Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHDMadan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib.
